Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 16621113)

Published in Diabetes Res Clin Pract on April 18, 2006

Authors

M Jansà1, M Vidal, J Viaplana, I Levy, I Conget, R Gomis, E Esmatjes

Author Affiliations

1: Diabetes Unit, Hospital Clínic, Barcelona, Spain. mjansa@clinic.ub.es

Associated clinical trials:

Telemedicine Program in Type 1 Diabetes and CSII | NCT02790645

Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients (PLATEDIAN) (PLATEDIAN) | NCT03332472

Articles citing this

The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review. J Med Internet Res (2007) 1.90

The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care (2011) 1.90

Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res (2013) 1.76

Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ (2013) 1.67

Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol (2010) 1.67

Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Cost Eff Resour Alloc (2009) 1.44

Management of diabetes mellitus in infants. Nat Rev Endocrinol (2011) 1.40

Home telemonitoring for type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser (2009) 0.95

Computer-mediated patient education: opportunities and challenges for supporting women with ovarian cancer. Nurs Clin North Am (2009) 0.84

Managing diabetes mellitus using information technology: a systematic review. J Diabetes Metab Disord (2015) 0.84

Cost-benefit analysis of internet therapeutic intervention on patients with diabetes. Int J Endocrinol Metab (2015) 0.79

Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ (2016) 0.78

Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Front Pharmacol (2017) 0.76

Articles by these authors

Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36

GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol (2000) 7.46

Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet (2001) 7.16

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32

Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10

A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature (1989) 4.17

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev (1998) 4.06

Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat Genet (2001) 4.03

The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75

Identification of a family of human F-box proteins. Curr Biol (1999) 3.31

High-throughput yeast two-hybrid assays for large-scale protein interaction mapping. Methods (2001) 3.09

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99

RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev (1996) 2.92

Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91

Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82

A protein-protein interaction map of the Caenorhabditis elegans 26S proteasome. EMBO Rep (2001) 2.74

Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J (1990) 2.56

A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci U S A (1996) 2.54

Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation (1994) 2.53

The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol Cell Biol (1989) 2.52

Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast (2000) 2.51

Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia (2004) 2.44

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia (2012) 2.43

Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet (1993) 2.40

Protein interaction maps for model organisms. Nat Rev Mol Cell Biol (2001) 2.32

Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway. Genes Dev (1997) 2.26

Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development (2001) 2.21

RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J (1999) 2.11

[Evaluation of functional capability after hospital admission of nonagenarian patients]. Med Clin (Barc) (2000) 2.01

The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99

Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94

Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia (2002) 1.93

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84

Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain. EMBO J (1997) 1.67

High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. Genes Dev (1989) 1.63

Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol (1994) 1.60

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ (2008) 1.58

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia (2004) 1.57

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55

Infected hydrocele following laparoscopic appendectomy: case report. Surg Laparosc Endosc (1997) 1.54

Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development (2000) 1.50

Deleterious effect of dithizone-DMSO staining on insulin secretion in rat and human pancreatic islets. Pancreas (1994) 1.45

Exserohilum: an emerging human pathogen. Eur J Clin Microbiol Infect Dis (2006) 1.45

Production of monoclonal antibodies against mammalian Ring1B proteins. Hybridoma (2001) 1.44

Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci U S A (1996) 1.42

Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex. Mol Biol Cell (2001) 1.41

New best estimates for radionuclide solid-liquid distribution coefficients in soils. Part 3: miscellany of radionuclides (Cd, Co, Ni, Zn, I, Se, Sb, Pu, Am, and others). J Environ Radioact (2008) 1.40

Staphylococcus aureus dissemination to a preexisting subdural hematoma. Pediatr Infect Dis J (1996) 1.39

Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol (2001) 1.39

A NEW METHOD FOR TESTING THE SENSE OF SMELL AND FOR THE ESTABLISHMENT OF OLFACTORY VALUES OF ODOROUS SUBSTANCES. Science (1936) 1.37

Olfactory marker protein gene: its structure and olfactory neuron-specific expression in transgenic mice. Proc Natl Acad Sci U S A (1989) 1.37

Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur J Biochem (2000) 1.35

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS (1999) 1.34

Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol (1997) 1.32

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Trends in mammography and Pap smear utilization in Canada. Chronic Dis Can (1996) 1.29

A genetic strategy to eliminate self-activator baits prior to high-throughput yeast two-hybrid screens. Genome Res (1999) 1.28

Gastric outlet obstruction by gallstone: Bouveret syndrome. Scand J Gastroenterol (2000) 1.27

Gastrointestinal complications of von Recklinghausen's disease: two case reports and a review of the literature. Scand J Gastroenterol (2003) 1.25

Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect (2006) 1.23

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci U S A (1995) 1.22

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care (1998) 1.20

Prediction of trace element mobility in contaminated soils by sequential extraction. J Environ Qual (2003) 1.19

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM (2009) 1.17

Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. Blood (1998) 1.17

Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.15

Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4. Diabetologia (2008) 1.14

Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol (2003) 1.13

Nonoperative management of unusual blunt traumatic rupture of the thoracic aorta. Tex Heart Inst J (1982) 1.13

Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes. Diabetes Care (2000) 1.12

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein. Virology (1998) 1.12

Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol (2011) 1.10

Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab (1983) 1.10

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. Ann Oncol (2011) 1.09

4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol (1999) 1.09

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09

The 1997 ADA diabetes diagnostic categories: impact on employees' annual medical examination. Diabet Med (1999) 1.08

Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08

Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08

Retroperitoneal cystic lymphangioma. Report of two cases and review of the literature. Cleve Clin Q (1972) 1.08

Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol (1996) 1.07

A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J (1999) 1.07

4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes (1998) 1.07

Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes (1999) 1.06

Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06

A soil sampling strategy for mapping trace element concentrations in a test area. Sci Total Environ (2001) 1.06

Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins. J Virol (1997) 1.05

The impending Canadian prostate cancer epidemic. Can J Public Health (1996) 1.05

Müllerianosis of the urinary bladder: clinical and immunohistochemical findings. Histopathology (1998) 1.05

Synthesis and biological evaluation of new diisocyanide- and triisocyanide-99mTc complexes. Appl Radiat Isot (1996) 1.04

Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04